Mirikizumab Beats Placebo, Secukinumab for Psoriasis ...Middle East

Medscape - News
52-week trial data pitting an interleukin-23 drug against an IL-17 inhibitor and placebo offers insight on efficacy and safety. Medscape Medical News

Hence then, the article about mirikizumab beats placebo secukinumab for psoriasis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirikizumab Beats Placebo, Secukinumab for Psoriasis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News